Message from CEO
Greeings
Spera Nexus was established on June 1, 2021, through the integration of the trading and manufacturing divisions of the pharmaceutical raw materials business within the Astena Group.
Our strength is the integration of the extensive information and networking capabilities inherent in a pharmaceutical raw materials trading company, combined with the advanced manufacturing and development expertise that has been accumulated and refined over many years as a pharmaceutical raw materials manufacturer. We will continue to invest in sustainable growth, thereby enhancing our long-term corporate value.
Our group companies are well-positioned to meet diverse customer needs across the pharmaceutical development and supply platform, with Spera Pharma specializing in CMC development services for small molecules and the contract manufacturing of investigational APIs and drugs, JITSUBO focusing on the development of medium-sized molecule pharmaceuticals, and IWAKI SEIYAKU SAKURA FACTORY providing contract manufacturing services for solid, semi-solid, and injectable formulations.
We sincerely ask for continued support as efforts are made to further strengthen the partnership.
President & CEO Keitaro Iwaki
page top